The first World Trade Organization meeting to discuss a draft agreement to temporarily waive intellectual property rights for COVID-19 vaccines went “very well”, its chair said on May 6.

The head of the World Trade Organization told Reuters on April 14 that negotiations on an intellectual property deal for COVID-19 vaccines were ongoing between the four parties, saying they were seeking to agree on the proposal’s final terms.

Eli Lilly & Co. said a federal court ruled that generic products proposed by a Teva Pharmaceutical Industries Ltd. TEVA -0.43 % unit would infringe a U.S. patent for the drug maker’s blockbuster cancer drug Alimta. A Teva spokesman said “we are disappointed with the district court’s decision and we are evaluating our options to […]